Moreover, we have also demonstrated that the level of POLD1 immunoexpression in tumor cells does not correlate with the demographic and clinicopathological characteristics of ccRCC patients [15]. This evidence concerns the gene POLD1 and nonpapillary renal cell carcinoma.